Biochemical and Biophysical Research Communications
Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle
Section snippets
Materials and methods
Human skeletal muscle samples. Fifteen healthy voluntary men aged between 25 and 45 years without any drug therapy that could interfere with the results of the study, were recruited. Informed consent was obtained from all the subjects after explanation of the protocol. The study was approved by the local Ethic Committee and conformed to the Declaration of Helsinki regarding the use of human subject. Muscle biopsies were performed in the inferior third level of the Vastus lateralis muscle under
Effects of simvastatin on cytosolic [Ca2+]i
Acute applications of simvastatin resulted in a delayed (∼10 min) wave of [Ca2+]i characterized typically by a large transient phase followed by a sustained elevation in Ca2+ (Fig. 1A). The increase in [Ca2+]i, that was to some extent comparable to that observed under caffeine application, triggered a prolonged contraction of the fibers. This effect was also observed on non-permeabilized intact muscle fibers (not shown), indicating that simvastatin is able to diffuse through the sarcolemma.
In
Discussion
In this work, we report that an acute application of simvastatin on human muscle fibers triggers a large increase in cytoplasmic Ca2+. This effect results first from an alteration of mitochondrial function by statins leading to mitochondrial membrane depolarization and Ca2+ efflux to the cytoplasm through the PTP and NCE. Then, Ca2+ is recaptured by the SR until it reaches a level that triggers the SR release. This dysregulation of Ca2+ homeostasis, implicating several cellular compartments and
Acknowledgments
This study was supported by INSERM, the Association Française contre les Myopathies (AFM), and the Fondation pour la Recherche Médicale (FRM). We are thankful to Dr. C.W. Ward for early assistance in spark analysis and Dr. F. Joubert for preliminary experiments on NADH autofluorescence measurements.
References (41)
- et al.
Involvement of tyrosine phosphorylation in HMG-CoA reductase inhibitor-induced cell death in L6 myoblasts
FEBS Lett.
(1999) - et al.
Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors
Biochem. Biophys. Res. Commun.
(1994) - et al.
Effects of HMG-CoA reductase inhibitors on excitation–contraction coupling of rat skeletal muscle
Eur. J. Pharmacol.
(1999) - et al.
Ca2+-releasing effect of cerivastatin on the sarcoplasmic reticulum of mouse and rat skeletal muscle fibers
J. Pharmacol. Sci.
(2003) - et al.
Clonazepam and diltiazem both inhibit sodium–calcium exchange of mitochondria, but only diltiazem inhibits the slow action potentials of cardiac muscles
Biochem. Biophys. Res. Commun.
(1985) - et al.
Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischemic rat hearts
Eur. J. Pharmacol.
(1995) - et al.
The origin of calcium overload in rat cardiac myocytes following metabolic inhibition with 2,4-dinitrophenol
J. Mol. Cell. Cardiol.
(2002) - et al.
Bupivacaine myotoxicity is mediated by mitochondria
J. Biol. Chem.
(2002) - et al.
Response of ryanodine receptor channels to Ca2+ steps produced by rapid solution exchange
Biophys. J.
(1996) - et al.
Transport mechanism for lovastatin acid in bovine kidney NBL-1 cells: kinetic evidences imply involvement of monocarboxylate transporter 4
Int. J. Pharm.
(2003)